Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Endothelial Foxo1 Phosphorylation Inhibition via Aptamer-Liposome Alleviates OPN-Induced Pathological Vascular Remodeling Following Spinal Cord Injury

Endothelial Foxo1 Phosphorylation Inhibition via Aptamer-Liposome Alleviates OPN-Induced Pathological Vascular Remodeling Following Spinal Cord Injury

Advanced Science, 2024 · DOI: 10.1002/advs.202406398 · Published: September 28, 2024

Spinal Cord InjuryCardiovascular SciencePharmacology

Simple Explanation

Spinal cord injuries (SCI) often lead to significant disabilities due to damage to the neurovascular unit. This study explores how specific vascular changes occur after SCI and how to target them for treatment. The research found that traumatic SCI causes pathological vascular remodeling, characterized by enlarged blood vessels, a disrupted blood-spinal cord barrier, and increased extracellular matrix deposition. The study also identified osteopontin (OPN) as a critical factor that contributes to this remodeling. By inhibiting Foxo1 phosphorylation, the researchers mitigated vascular remodeling, which improved axon regeneration and neurological function recovery after SCI.

Study Duration
Not specified
Participants
8-week-old female mice
Evidence Level
Not specified

Key Findings

  • 1
    Traumatic SCI leads to pathological vascular remodeling, including enlarged vessel diameter and disruption of the blood-spinal cord barrier.
  • 2
    Osteopontin (OPN) promotes vascular regeneration but also contributes to pathological vascular remodeling after SCI.
  • 3
    Targeted inhibition of Foxo1 phosphorylation mitigates vascular remodeling and enhances axon regeneration and neurological function recovery following SCI.

Research Summary

This study demonstrates that traumatic pathological vascular remodeling occurs during the chronic phase of injury, characterized by enlarged vessel diameter, disruption of blood-spinal cord barrier, endothelial-to-mesenchymal transition (EndoMT), and heightened extracellular matrix deposition. After SCI, osteopontin (OPN), a critical factor secreted by immune cells, is indispensable for early vascular regeneration but also contributes to traumatic pathological vascular remodeling. Targeted inhibition of Foxo1 phosphorylation through an endothelium-specific aptamer-liposome small molecule delivery system significantly mitigates vascular remodeling, thereby enhancing axon regeneration and neurological function recovery following SCI.

Practical Implications

Drug Therapies

The findings offer a novel perspective for drug therapies aimed at specifically targeting pathological vasculature after SCI.

Aptamer-Liposome Delivery

Aptamer-liposome-encapsulated small molecule can be developed for vascular therapy. This drug delivery system is designed to specifically target endothelial cells at the injury epicenter of SCI.

Clinical Application Potential

Intravenous administration of Apt-LP@Sar reduced fibrotic scar area and significantly promoted neural regeneration and functional recovery in mice post-SCI, showing promising clinical application potential.

Study Limitations

  • 1
    [object Object]
  • 2
    [object Object]
  • 3
    [object Object]

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury